| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/06/2005 | EP1549762A1 Methods for the enrichment of low-abundance polynucleotides |
| 07/06/2005 | EP1549761A1 Methods and compositions for the modification of nucleic acids |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549755A2 Spliceosome mediated rna trans-splicing in stem cells |
| 07/06/2005 | EP1549751A2 Recombinant adenoviral vectors and applications thereof |
| 07/06/2005 | EP1549750A1 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses thereof |
| 07/06/2005 | EP1549748A1 Single chain recombinant t cell receptors |
| 07/06/2005 | EP1549746A1 Tryptophan as a functional replacement for adp-ribose-arginine in recombinant proteins |
| 07/06/2005 | EP1549743A2 Commercial production of recombinant manganese-dependent peroxidase in plants |
| 07/06/2005 | EP1549736A2 Zymomonas pentose-sugar fermentating strains and uses thereof |
| 07/06/2005 | EP1549735A2 Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy |
| 07/06/2005 | EP1549676A1 Genes and polypeptides relating to human myeloid leukemia |
| 07/06/2005 | EP1549673A2 Novel mhc ii associated peptides |
| 07/06/2005 | EP1549672A2 Ablated slam-dependent entry |
| 07/06/2005 | EP1549671A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/06/2005 | EP1549664A2 Murine ortholog of the human disrupted-in-schizophrenia 1 gene |
| 07/06/2005 | EP1549663A2 Multifunctional polypeptides |
| 07/06/2005 | EP1549661A2 Targeted manipulation of genes in plants |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549659A2 Carotenoid ketolase gene |
| 07/06/2005 | EP1549611A2 S-adenosyl methionine decarboxylase inhibition for the treatment of a herpes simplex virus infection |
| 07/06/2005 | EP1549387A1 Antisense modulation of farnesoid x receptor expression |
| 07/06/2005 | EP1549352A2 Methods for delivery of nucleic acids |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549349A1 Non-viral gene delivery system |
| 07/06/2005 | EP1549341A2 Novel tissue factor targeted antibodies as anticoagulants |
| 07/06/2005 | EP1549340A1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 07/06/2005 | EP1549339A2 Targeting of herpes simplex virus to specific receptors |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549133A2 Fatty acid desaturases from fungi |
| 07/06/2005 | EP1549132A2 Temporal seed promoters for expressing genes in plants |
| 07/06/2005 | EP1421097A4 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 07/06/2005 | EP1395108A4 Sugar and lipid metabolism regulators in plants |
| 07/06/2005 | EP1390380A4 Methods and primers for evaluating hiv-1 mutations |
| 07/06/2005 | EP1368629A4 Magnetic isolation and purification of nucleic acids |
| 07/06/2005 | EP1349446A4 Modification of sucrose synthase gene expression in plant tissue and uses therefor |
| 07/06/2005 | EP1268531B1 Method for the production of bacterial toxins |
| 07/06/2005 | EP1230375B1 Inhibiting gene expression with dsrna |
| 07/06/2005 | EP1222280B1 Apoptosis inducing proteinaceous substance |
| 07/06/2005 | EP1203021B1 New sequence variants of the human beta-1-adrenoreceptor genes and use thereof |
| 07/06/2005 | EP1194587A4 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 07/06/2005 | EP1060264B1 Dideoxy dye terminators |
| 07/06/2005 | EP1045902B1 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME |
| 07/06/2005 | EP1017837B1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
| 07/06/2005 | EP0948650B1 Method for eliminating specific sequences when constructing dna libraries |
| 07/06/2005 | EP0914455B1 Transformation of zygote and recovery of transformed maize plants from isolated embryo sacs |
| 07/06/2005 | EP0870032B1 Polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | EP0730651B1 Surface loop structural analogues of fibroblast growth factors |
| 07/06/2005 | CN2707764Y Hybrid simplified box type device |
| 07/06/2005 | CN1636138A Magneto-optical bio-discs and systems including related methods |
| 07/06/2005 | CN1636137A Microarray method of genotyping multiple samples at multiple loci |
| 07/06/2005 | CN1636071A Diagnostic assays for parvovirus B19 |
| 07/06/2005 | CN1636070A Nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/06/2005 | CN1636069A Method of determining a chemotherapeutic regimen based on ERCCI expression |
| 07/06/2005 | CN1636068A Method for correlating gene expression profiles with protein expression profiles |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636066A Method for producing vitamin B12 |
| 07/06/2005 | CN1636065A Herbicide-tolerant plants through bypassing metabolic pathway |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636063A Genetic vaccine against human immunodeficiency virus |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636060A Methods of delivery of exogenous proteins to the cytosol and uses thereof |
| 07/06/2005 | CN1636058A Novel alanine transaminase enzyme and methods of use |
| 07/06/2005 | CN1636056A Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 07/06/2005 | CN1636055A Isolation and expression of a gene for a nitrilase from acidovorax facilis 72W |
| 07/06/2005 | CN1636054A Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 07/06/2005 | CN1636052A Methods for producing hyaluronan in a recombinant host cell |
| 07/06/2005 | CN1636050A Core-glycosylated HCV envelope proteins |
| 07/06/2005 | CN1636019A Recombinant antibodies, and compositions and methods for making and using the same |
| 07/06/2005 | CN1636018A 组织特异性表达 Tissue-specific expression |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1636015A HCV e1e2 vaccine compositions |
| 07/06/2005 | CN1636013A DNA vaccines encoding HIV accessory proteins |
| 07/06/2005 | CN1636012A Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 07/06/2005 | CN1636010A Compositions for DNA mediated gene silencing |
| 07/06/2005 | CN1635988A Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 07/06/2005 | CN1635905A Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
| 07/06/2005 | CN1635902A Remedy for infections |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635898A Super-active porcine growth hormone releasing hormone analog |
| 07/06/2005 | CN1635895A Coffee plant with reduced alpha-D-galactosidase activity |
| 07/06/2005 | CN1635876A 人免疫缺陷病毒疫苗 Human immunodeficiency virus vaccine |
| 07/06/2005 | CN1635849A Bone anti-resorptive compounds |
| 07/06/2005 | CN1635121A Duck plague herpesvirus transfer vector and method for making same |
| 07/06/2005 | CN1635120A ALBSIN/IL-18MAT hybridization cytokine |
| 07/06/2005 | CN1635119A Process for preparing amyloidosis polypeptide beta (Abeta), a senile dementia causing substance, and product yield thereof |
| 07/06/2005 | CN1635118A Synthesis of carcinoembryonic antigen peptide epitope gene coded sequence concatemer and epitope vaccine thereof |
| 07/06/2005 | CN1635117A Novel process for preparing recombinant Exendin-4 polypeptide |
| 07/06/2005 | CN1634995A Arginine deacylase fusion protein, method for preparation and application |
| 07/06/2005 | CN1634994A Antineoplastic rat light chain single domain antibody - Cefuroxime Sodium reinforced fusion protein VL-LDP-AE |
| 07/06/2005 | CN1634992A Method for optimizing and extracting rabbit-anti-human ATP7Bn33-629 polyclone antibodies |
| 07/06/2005 | CN1634991A Human anti-tetanotoxin monoclonal antibody, method for preparation and application |
| 07/06/2005 | CN1634990A High affinity immune globulin binding molecule and method for preparation |
| 07/06/2005 | CN1634986A A novel Kunin type polypeptide and method for making same |
| 07/06/2005 | CN1634985A Pig Ghrelin derivative, its encoding gene and application |
| 07/06/2005 | CN1634984A Alfalfa Na+/H+ reverse transporting protein, its encoding gene and application |
| 07/06/2005 | CN1634982A A portion of extracellular domain peptide segment of eukaryotic cells secretion expressed carcinembryonic antigen |
| 07/06/2005 | CN1634981A A plurality of antibiotic peptides, method for preparation and use thereof |